Rush Alzheimer's Disease Research Center
拉什阿尔茨海默病研究中心
基本信息
- 批准号:10264493
- 负责人:
- 金额:$ 312.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyBiologicalBiological MarkersBiometryBrainCaregiversCell modelClergyClinicalCohort StudiesCommunitiesCrystallizationDataData CollectionData SetDementiaDisease modelEducationEnrollmentEvaluationExerciseFacultyFundingGoalsGrantHeterogeneityHumanImpaired cognitionIncentivesInfrastructureInstitutionLatinoLeadershipMagnetic Resonance ImagingMethodologyMolecular ProfilingNatureOrgan DonationsParticipantPathogenesisPatientsPersonsPilot ProjectsPositron-Emission TomographyPreventionProceduresProcessPublishingRecommendationReproducibilityResearchResearch PersonnelResearch Project GrantsResourcesScienceSourceSpecimenStrategic PlanningStructureSystems BiologyTrustWorkcohortcollaborative environmentcommunity based researchcomputer infrastructurecomputerized toolsdata harmonizationdata managementdata sharingdistributed dataeducation researchethnic minority populationfollow-uphuman datainnovationmultidisciplinaryneuroimagingneuroimaging markerneuropathologynew therapeutic targetopen dataoutreachpredictive modelingprogramspublic health prioritiespublic-private partnershipracial and ethnicracial diversityracial minorityrecruitrelational databasereligious order studyrepositorystatisticsstudent mentoringvirtual
项目摘要
ABSTRACT – OVERALL
The overall goal of the proposed Rush ADRC is to create an inter-disciplinary environment that supports
innovative research on the causes, treatments, and prevention of AD/ADRD. While the proposed Rush ADRC
is for a new grant, it builds on three decades of work by the current Rush ADCC. The Rush ADRC has eight
cores and one component, which align with the recommendations of the 2017 NIA strategic plan, including
studies that: 1) recognize the heterogeneity and multifactorial nature of dementias; 2) support extensive
molecular profiling to fill the gaps in large-scale human data needed to build predictive models of disease and
wellness; 3) employ new research paradigms, e.g., systems biology, human cell modeling; 4) enable rapid and
extensive sharing of data, disease models, specimens, and support open and team science; 5) develop
computational tools and infrastructure for storage, integration, and analysis of large-scale biological and
patient-relevant data; 6) build multidisciplinary translational teams in virtual and real spaces; 7) develop new
pre-competitive public-private partnerships; 8) change academic, publishing, and funding incentives to promote
collaborative, transparent, and reproducible research; and 9) engage patients, caregivers, and citizens as
direct partners in research.
The Administrative Core will provide scientific leadership to the Rush ADRC as a whole. The Religious Orders
Study (ROS) Core will recruit and conduct annual evaluations of Catholic clergy without dementia who agree to
organ donation. The Clinical and Latino Cores will collect data harmonized with on Blacks and Latinos without
dementia and work to obtain brain autopsy. The Neuropathology Core will process, store, evaluate and
distribute biospecimens obtained by the Clinical, ROS, and Latino Cores. The Outreach, Recruitment, and
Engagement Core will provide a wide range of educational programs to support outreach and recruitment of
racial and ethnic minorities into the Clinical, ROS and Latino Cores, and other NIA funded initiatives. The
Biomarker/Neuroimaging Core will process neuroimaging generated with other funds from all three Cores and
affiliated studies, and document neuroimaging and biofluid biomarker data. The new Research and Education
Component will provide structured mentoring of students and faculty at all levels. The Data Management and
Statistical Core will provide the infrastructure that allows all other Cores and the REC to be maximally
successful and impactful and will provide statistical support to users of ADRC resources especially junior
investigators and trainees.
摘要 – 总体
拟议的 Rush ADRC 的总体目标是创建一个跨学科环境,以支持
AD/ADRD 的病因、治疗和预防方面的创新研究,同时提出了 Rush ADRC。
这是一项新的资助,它建立在当前 Rush ADCC 三十年的工作基础上。 Rush ADRC 有八项资助。
核心和一个组件,符合 2017 年 NIA 战略计划的建议,包括
研究:1)认识到痴呆症的异质性和多因素性质;2)支持广泛的研究;
分子分析填补了建立疾病预测模型所需的大规模人类数据的空白
健康;3)采用新的研究范式,例如系统生物学、人体细胞建模;4)实现快速和
广泛共享数据、疾病模型、标本,并支持开放和团队科学 5) 发展;
用于存储、集成和分析大规模生物和生物信息的计算工具和基础设施
患者相关数据;6)在虚拟和现实空间中建立多学科转化团队;7)开发新的
竞争前的公私合作伙伴关系;8)改变学术、出版和资助激励措施以促进
协作、透明和可重复的研究;9) 让患者、护理人员和公民参与其中
研究的直接合作伙伴。
行政核心将为整个 Rush ADRC 提供科学领导。
研究(ROS)核心将招募同意的无痴呆症天主教神职人员并进行年度评估
临床和拉丁裔核心将收集与黑人和拉丁裔协调一致的数据。
神经病理学核心将处理、存储、评估和进行脑部尸检。
分发临床、ROS 和拉丁裔核心获得的生物样本。
参与核心将提供广泛的教育计划,以支持外展和招聘
将种族和族裔纳入临床、ROS 和拉丁裔核心以及其他 NIA 资助的计划中。
生物标记/神经影像核心将处理由所有三个核心的其他资金生成的神经影像,
附属研究,并记录神经影像和生物流体生物标志物数据。
该组件将为各级学生和教师提供结构化指导。
统计核心将提供允许所有其他核心和 REC 最大化的基础设施
成功且有影响力,将为 ADRC 资源的用户,特别是初级用户提供统计支持
调查员和实习生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID ALAN BENNETT其他文献
DAVID ALAN BENNETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID ALAN BENNETT', 18)}}的其他基金
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
新型和改造疗法在不同人群中治疗阿尔茨海默病和相关痴呆症的使用和影响
- 批准号:
10655203 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
- 批准号:
10590405 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10404653 - 财政年份:2019
- 资助金额:
$ 312.77万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10655334 - 财政年份:2019
- 资助金额:
$ 312.77万 - 项目类别:
相似国自然基金
运动预防阿尔茨海默病的脑脊液关键因子及其“损伤-修复”机制研究
- 批准号:32300959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长期有氧运动预防阿尔茨海默病的OPCs衰老机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
游泳训练预防阿尔茨海默病的线粒体机制研究
- 批准号:31871205
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
A multi-omic and integrative longitudinal evaluation of the role of lipid, antioxidant, and osmoprotectant metabolites in the genitourinary syndrome of menopause by race and ethnicity.
按种族和民族对脂质、抗氧化剂和渗透保护代谢物在更年期泌尿生殖综合征中的作用进行多组学和综合纵向评估。
- 批准号:
10643444 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Accelerating digital cognitive screening for Alzheimer's disease in the Primary Care Setting
加速初级保健机构中阿尔茨海默病的数字认知筛查
- 批准号:
10664618 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-Americans
使用健康差异研究框架来研究老年黑人/非裔美国人中阻塞性睡眠呼吸暂停与阿尔茨海默病较高风险之间的联系机制
- 批准号:
10662903 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Saliva based protein markers for predicting the risk of cognitive decline and dementia in older adults.
基于唾液的蛋白质标记物可预测老年人认知能力下降和痴呆的风险。
- 批准号:
10662974 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别:
Cognitive Aging Trajectories in Survivors of Trauma
创伤幸存者的认知老化轨迹
- 批准号:
10662957 - 财政年份:2023
- 资助金额:
$ 312.77万 - 项目类别: